Exact Sciences Corporation
Clinical trials sponsored by Exact Sciences Corporation, explained in plain language.
-
150,000-Person study reveals Real-World power of At-Home colon cancer test
Diagnosis OngoingThis study follows 150,000 people in the U.S. who were prescribed the Cologuard stool test for colorectal cancer screening. Researchers want to see how many people get a follow-up colonoscopy after a positive result, how often cancer is found, and how these numbers compare to nat…
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated May 17, 2026 03:53 UTC
-
New blood test could spot liver cancer earlier than ultrasound
Diagnosis OngoingThis study is testing a new blood test called Oncoguard™ Liver to see how well it finds liver cancer early in people who are at high risk, such as those with cirrhosis or hepatitis B. About 2,990 adults will take part, and the test's accuracy will be compared to standard ultrasou…
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
Blood test may spot cancer return before symptoms appear
Knowledge-focused OngoingThis study looks at whether a simple blood test can find tiny bits of cancer DNA left in the body after surgery for stage II or III colorectal cancer. Over 1,000 participants will be followed for up to 7 years to see if the test can predict cancer coming back earlier than standar…
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC